There is a low but increased risk of optic nerve disorders in patients with type 2 diabetes prescribed semaglutide or ...

About The Study: In this study of patients with type 2 diabetes who had no prior eye disorders, patients prescribed semaglutide or tirzepatide had an increased risk of nonarteritic anterior ...

Study: Semaglutide or Tirzepatide and Optic Nerve and Visual Pathway Disorders in Type 2 Diabetes. Image credit: Vince Scherer/Shutterstock.com A study published in JAMA Network Open reported that ...

Xu and co-authors looked specifically at use of semaglutide or tirzepatide, the two most widely prescribed GLP-1 agonists, and risk of new diagnoses of optic nerve or visual pathway disorders in ...

Definitive conclusions regarding the association between semaglutide and nonarteritic anterior ischemic optic neuropathy ...

Cortical Visual Impairment refers to a brain condition, not an eye condition and results from damage to the visual systems in the brain that deal with processing and integrating visual information.

Visual acuity was generally normal in spite of gross visual field constriction. Conclusion: We believe that VGB should be used with great caution where there is pre-existing visual pathway damage.